Are Gilead Shares Overreacting To Merck's Idenix Acquisition? By: Benzinga via Benzinga June 09, 2014 at 14:34 PM EDT Shares of Gilead Sciences (NASDAQ: GILD) have fallen over four percent following Merck's (NYSE: MRK) purchase of Idenix ... Read More >> Related Stocks: Enanta Pharmaceutica Gilead Sciences Macy's Merck & Co RBC Bearings Inc